🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s EWTX Holdings & Trades

First Buy
Q3 2024
Duration Held
5 Quarters
Largest Add
Q4 2025
+13,746 Shares
Current Position
13,746 Shares
$341,106 Value

Cliff Asness's EWTX Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 13,746 shares of Edgewise Therapeutics, Inc. (EWTX) worth $341,106, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.

Based on 13F filings, Cliff Asness has maintained this position in EWTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 13,746 shares. Largest reduction occurred in Q2 2025, reducing 9,419 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Edgewise Therapeutics (EWTX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Edgewise Therapeutics (EWTX) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +13,746 New Buy 13,746 $24.81
Q2 2025 -9,419 Sold Out 0 $0.00
Q1 2025 +53 Add 0.57% 9,419 $22.00
Q4 2024 +420 Add 4.69% 9,366 $26.70
Q3 2024 +8,946 New Buy 8,946 $26.69

Cliff Asness's Edgewise Therapeutics Investment FAQs

Cliff Asness first purchased Edgewise Therapeutics, Inc. (EWTX) in Q3 2024, acquiring 8,946 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Edgewise Therapeutics, Inc. (EWTX) for 5 quarters since Q3 2024.

Cliff Asness's largest addition to Edgewise Therapeutics, Inc. (EWTX) was in Q4 2025, adding 13,746 shares worth $341,106.

According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 13,746 shares of Edgewise Therapeutics, Inc. (EWTX), valued at approximately $341,106.

As of the Q4 2025 filing, Edgewise Therapeutics, Inc. (EWTX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Edgewise Therapeutics, Inc. (EWTX) was 13,746 shares, as reported at the end of Q4 2025.